These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 15823633

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Cardioprotective effect of erythropoietin preparations in patients with chronic renal failure].
    Nikolaev AIu, Ermolenko VM, Milovanova LIu, Milovanov IuS.
    Ter Arkh; 2004; 76(9):40-3. PubMed ID: 15532375
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N, Sriuranpong V, Suwanrusme H.
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [Abstract] [Full Text] [Related]

  • 5. Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer.
    Hoskin PJ, Robinson M, Slevin N, Morgan D, Harrington K, Gaffney C.
    J Clin Oncol; 2009 Dec 01; 27(34):5751-6. PubMed ID: 19884550
    [Abstract] [Full Text] [Related]

  • 6. Relationship between hemoglobin level and quality of life in anemic patients with chronic kidney disease receiving epoetin alfa.
    Lefebvre P, Vekeman F, Sarokhan B, Enny C, Provenzano R, Cremieux PY.
    Curr Med Res Opin; 2006 Oct 01; 22(10):1929-37. PubMed ID: 17022852
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Left ventricular hypertrophy in patients on hemodialysis: importance of anemia].
    Stojimirović B, Petrović D, Obrenović R.
    Med Pregl; 2007 Oct 01; 60 Suppl 2():155-9. PubMed ID: 18928184
    [Abstract] [Full Text] [Related]

  • 11. Patients previously transfused or treated with epoetin alfa at low baseline hemoglobin are at higher risk for subsequent transfusion: an integrated analysis of the Canadian experience.
    Quirt I, Kovacs M, Couture F, Turner AR, Noble M, Burkes R, Dolan S, Plante RK, Lau CY, Chang J.
    Oncologist; 2006 Jan 01; 11(1):73-82. PubMed ID: 16401716
    [Abstract] [Full Text] [Related]

  • 12. Hemoglobin response and influence on left ventricular hypertrophy after 24-week treatment of a biosimilar epoetin-alfa in hemodialysis patients with anemia.
    Thanakitcharu P, Siriwiwatanakul N.
    J Med Assoc Thai; 2007 Dec 01; 90(12):2574-86. PubMed ID: 18386706
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: a 19-week, phase II, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease.
    Besarab A, Salifu MO, Lunde NM, Bansal V, Fishbane S, Dougherty FC, Beyer U, Ba16285 Study Investigators.
    Clin Ther; 2007 Apr 01; 29(4):626-39. PubMed ID: 17617286
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The cardiovascular and hemodynamic effects of erythropoietin in chronic renal failure.
    Singh NP, Chandrashekhar, Nair M, Anuradha S, Kohli R, Agarwal SK.
    J Assoc Physicians India; 2000 Mar 01; 48(3):301-6. PubMed ID: 11229114
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.